Strategic discovery leader with 9 years of industry experience and 20+ years in research, specializing in oncology and immunology. I have helped Roche advance innovative therapies from discovery through clinical development, with a focus on translating cutting-edge science into life-saving treatments. Leveraging my expertise in due diligence, I have successfully evaluated external partnerships and opportunities, fostering impactful scientific collaborations. Beyond my work at Roche, I contribute to the broader scientific community as a board member of Keystone Symposia, helping to shape the global discourse in immunology and cancer research.

Key achievements include:

• Co-leading a dynamic discovery department at Roche, driving next-generation therapies in immunology and cancer into Phase I clinical trials.
• Spearheading a machine learning-driven automation initiative that developed a therapeutic binder three times faster than our partner.
• Successfully advancing a critical therapeutic candidate from initial portfolio entry to a first-in-human clinical trial within six years. This achievement was made possible by identifying key challenges early in the development process and designing an innovative safety model to address them, enabling targeted activation of specific receptors in a controlled manner.

I’m excited about opportunities to drive innovation in drug discovery by leveraging emerging technologies

I love connecting with like-minded professionals passionate about advancing science and improving patient outcomes. Feel free to reach out at stgasser1aticloud.com.